| Thousands of deaths from kidney or renal failure following heart surgery have been linked to Trasylol (aprontinin). On February 17, 2008, 60 minutes reported that according to a renowned researcher 22,000 patients died because the Food and Drug Administration did not remove the heart surgery drug Trasylol two years ago, when his study revealed widespread death associated with it. At a meeting called by the FDA to discuss the safety profile of Trasylol, the drug’s manufacturer, Bayer, failed to tell the FDA about negative results of their own Trasylol study, which also showed that Trasylol was linked to kidney failure, death, heart attack, and stroke. A Canadian study designed to test for kidney failure and death with Trasylol had to be stopped because of severe injury and death to patients. |
| We are reviewing cases for individuals who have received an injection prior to heart surgery, and within two weeks of the injection suffered:
kidney failure
stroke
heart attack
death
|
|
|
|
| Trasylol linked to heart attack, stroke, kidney failure and death. Bayer did a study showing this and forgot to tell the FDA. Thousands died. |
| Our law firm is investigating these cases. |
|
|
|
|
